Business Wire

Xsolla Unveils Cloud Gaming Trials to Convert Game Demos Into Revenue

15.8.2025 15:00:00 CEST | Business Wire | Press release

Share

Upgraded Cloud Gaming Solution Helps Developers Convert More Players into Payers with Instant Access, Smarter Campaigns, and Full Control Over Game Trials, No Downloads, No Installs

Xsolla, a global commerce company helping developers launch, grow and monetize their games, announces today game trials as a new focus for its Cloud Gaming solution. Designed to help developers and publishers boost visibility, player acquisition, and conversion, the upgraded Cloud Gaming solution bridges the gap between marketing and monetization by enabling instant game access, real-time performance tracking, and flexible pay-to-play models.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250815871365/en/

(Graphic: Xsolla)

In an increasingly competitive cloud gaming market projected to surpass $10.4 billion in global revenue by 2025, developers are seeking scalable and cost-effective ways to engage players both before and after launch. With over 19,000 games added to Steam in 2024 alone, visibility and differentiation are more critical than ever. Xsolla’s upgraded Cloud Gaming solution addresses these challenges by offering a frictionless way for players to try games instantly in the browser, while enabling publishers to monetize that engagement through in-stream purchases, game key sales, and direct referrals.

Players can instantly launch a game without downloads or installs with a simple “Play Now” button or deep-link listing on x.la/cloud-gaming. Using our “Play Before You Buy” feature, players can try the game for up to 15 minutes in a cloud-streamed session before deciding to purchase. These trial experiences support pay-as-you-go monetization and full-game purchases through direct key sales, including platforms like Steam, PlayStation, Xbox, Nintendo Switch, and Epic Games, all accessible through the in-stream overlay.

Key benefits of Xsolla Cloud Gaming Trials include:

  • Instant Game Access: One-click browser-based demos with no install required.
  • Flexible Monetization Models: Support for play-before-you-buy, pay-as-you-go, and direct key sales.
  • Publisher Control: Full ownership over data, player journeys, and campaign performance.
  • Marketing Attribution: Real-time tracking of engagement, referral sources, and conversion.
  • Controlled Distribution: Whitelisting tools for media access, VIP demos, or phased campaign launches.
  • Global Reach with Lower Cost: Direct-to-consumer and Xsolla Mall distribution lowers acquisition costs.

“With Cloud Gaming Trials, we’ve created a powerful way to transform marketing campaigns into measurable sales engines,” said Chris Hewish, President at Xsolla. “You no longer need to wait for a wishlist or an install; we’re giving the ability to provide players with instant access to their favorite games while giving developers full control over what happens next.”

Cloud Gaming Trials is ideal for pre-launch community building and post-launch re-engagement. Studios can list demos on Xsolla’s cloud store to drive early interest and conversion. Once live, publishers can use the same tools to enable sampling, track click-through-to-purchase rates, and adjust campaign targeting based on performance. By combining flexible monetization with actionable data, developers can optimize marketing spend and grow their audience more effectively.

Unlike traditional marketplaces where visibility is algorithm-dependent and analytics are limited, Xsolla Cloud Gaming Trials puts discovery and data back in the hands of creators. The platform empowers teams to run whitelisted demos for press, partners, or influencers, enabling targeted promotions without public exposure.

Xsolla invites developers, studios, and publishers to utilize Cloud Gaming Trials to boost conversion, expand player reach, and streamline campaign execution.

To start or list your game on the Xsolla Cloud Store, visit x.la/cloud-gaming or contact the Xsolla Publisher team.

For a complete list of enhancements and developer tools, visit: xsolla.pro/rws25cloudgaming

About Xsolla

Xsolla is a global commerce company with robust tools and services to help developers solve the inherent challenges of the video game industry. From indie to AAA, companies partner with Xsolla to help them fund, distribute, market, and monetize their games. Grounded in the belief in the future of video games, Xsolla is resolute in the mission to bring opportunities together, and continually make new resources available to creators. Headquartered and incorporated in Los Angeles, California, Xsolla operates as the merchant of record and has helped over 1,500+ game developers to reach more players and grow their businesses around the world. With more paths to profits and ways to win, developers have all the things needed to enjoy the game.

For more information, visit xsolla.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250815871365/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release

Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye